Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.650
+0.150 (4.29%)
At close: Mar 9, 2026, 4:00 PM EDT
3.630
-0.020 (-0.55%)
After-hours: Mar 9, 2026, 4:58 PM EDT
Ironwood Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 296.15 | 351.41 | 442.74 | 410.6 | 413.75 | Upgrade
|
| Revenue Growth (YoY) | -15.72% | -20.63% | 7.83% | -0.76% | 6.22% | Upgrade
|
| Cost of Revenue | 95.14 | 111.42 | 104.79 | 44.27 | 70.41 | Upgrade
|
| Gross Profit | 201.02 | 239.99 | 337.95 | 366.33 | 343.35 | Upgrade
|
| Selling, General & Admin | 82.26 | 144.27 | 142.11 | 115.99 | 111.13 | Upgrade
|
| Operating Expenses | 82.26 | 144.27 | 142.11 | 115.99 | 111.13 | Upgrade
|
| Operating Income | 118.76 | 95.72 | 195.84 | 250.34 | 232.22 | Upgrade
|
| Interest Expense | -32.75 | -33.29 | -21.38 | -7.6 | -31.15 | Upgrade
|
| Interest & Investment Income | 4.08 | 4.47 | 18.97 | 9.5 | 0.73 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.19 | 0.89 | -0.23 | 0.18 | -1.18 | Upgrade
|
| EBT Excluding Unusual Items | 90.28 | 67.79 | 193.2 | 252.42 | 200.61 | Upgrade
|
| Merger & Restructuring Charges | -20.26 | -2.59 | -45.82 | - | 0.04 | Upgrade
|
| Pretax Income | 70.03 | 65.2 | -948.07 | 252.42 | 200.66 | Upgrade
|
| Income Tax Expense | 46.01 | 64.32 | 83.49 | 77.36 | -327.79 | Upgrade
|
| Earnings From Continuing Operations | 24.02 | 0.88 | -1,032 | 175.07 | 528.45 | Upgrade
|
| Net Income to Company | 24.02 | 0.88 | -1,032 | 175.07 | 528.45 | Upgrade
|
| Minority Interest in Earnings | - | - | 29.32 | - | - | Upgrade
|
| Net Income | 24.02 | 0.88 | -1,002 | 175.07 | 528.45 | Upgrade
|
| Net Income to Common | 24.02 | 0.88 | -1,002 | 175.07 | 528.45 | Upgrade
|
| Net Income Growth | 2629.20% | - | - | -66.87% | 397.71% | Upgrade
|
| Shares Outstanding (Basic) | 162 | 159 | 155 | 154 | 162 | Upgrade
|
| Shares Outstanding (Diluted) | 163 | 160 | 155 | 186 | 164 | Upgrade
|
| Shares Change (YoY) | 1.81% | 2.99% | -16.57% | 13.32% | 2.34% | Upgrade
|
| EPS (Basic) | 0.15 | 0.01 | -6.45 | 1.13 | 3.26 | Upgrade
|
| EPS (Diluted) | 0.15 | 0.01 | -6.45 | 0.96 | 3.21 | Upgrade
|
| EPS Growth | 2583.01% | - | - | -69.98% | 386.36% | Upgrade
|
| Free Cash Flow | 127.01 | 103.41 | 183.15 | 273.63 | 261.63 | Upgrade
|
| Free Cash Flow Per Share | 0.78 | 0.65 | 1.18 | 1.47 | 1.59 | Upgrade
|
| Gross Margin | 67.88% | 68.29% | 76.33% | 89.22% | 82.98% | Upgrade
|
| Operating Margin | 40.10% | 27.24% | 44.23% | 60.97% | 56.12% | Upgrade
|
| Profit Margin | 8.11% | 0.25% | -226.37% | 42.64% | 127.72% | Upgrade
|
| Free Cash Flow Margin | 42.89% | 29.43% | 41.37% | 66.64% | 63.23% | Upgrade
|
| EBITDA | 120.64 | 97.73 | 197.41 | 251.76 | 233.74 | Upgrade
|
| EBITDA Margin | 40.74% | 27.81% | 44.59% | 61.31% | 56.49% | Upgrade
|
| D&A For EBITDA | 1.88 | 2.01 | 1.58 | 1.42 | 1.52 | Upgrade
|
| EBIT | 118.76 | 95.72 | 195.84 | 250.34 | 232.22 | Upgrade
|
| EBIT Margin | 40.10% | 27.24% | 44.23% | 60.97% | 56.12% | Upgrade
|
| Effective Tax Rate | 65.70% | 98.65% | - | 30.65% | - | Upgrade
|
| Revenue as Reported | 296.15 | 351.41 | 442.74 | 410.6 | 413.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.